GeorgeGrunbergerMDFACP, MACE

Diabetes, Lipid Metabolism, Obesity

Clinical Professor, Internal Medicine and Molecular Medicine & Genetics, Wayne State University School of Medicine Professor, Internal Medicine, Oakland University William Beaumont School of Medicine Visiting Professor, First Faculty of Medicine, Charles University, Prague (Czech Republic)

Join to view full profile

Dr. Grunberger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grunberger's full profile

Already have an account?

Office
43494 Woodward Ave
Ste 208
Bloomfield Hills, MI 48302
Phone+1 248-335-7740

Fax+1 248-338-7979

Education & Training

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1983
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1977 - 1980
New York University School of MedicineClass of 1977
Columbia CollegeB.S., Biochemistry, 1969 - 1973

Certifications & Licensure

MI State Medical License 1986 - 2026
MD State Medical License 1980 - 1986
OH State Medical License 1978 - 1979
American Board of Internal Medicine Internal Medicine
National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

Master American College of Endocrinology, 2020
Fellow American College of Endocrinology, 2000
Fellow American College of Physicians, 1983

Clinical Trials

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting Start of enrollment: 2012 Jan 01
Completed
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Standing balance impairment in persons with type 2 diabetes is predicted by peripheral neuropathy and vestibulopathy.
Trevor Lopatin, Kwame Sakyi, Bradley Kendall, George Grunberger, Joshua Haworth
Primary Care Diabetes. 2025-02-01
Retrospective derivation of a causal pathway for diabetic ketoacidosis in adult patients with type 2 diabetes mellitus.
Jeffrey A Kline, Nicholas A Wesner, Amina T Sharif, Richard T Griffey, Phillip D Levy
BMJ Open Diabetes Research & Care. 2024-12-20
3 citations
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.
Gregg D Simonson, Amy B Criego, Tadej Battelino, Anders L Carlson, Pratik Choudhary
Diabetes Technology & Therapeutics. 2024-11-01

Lectures

New Strategies for Obesity Management: Risk Stratification & Long-term Weight Control
American Association of Clinical Endocrinologists (AACE), Dearborn, Michigan - 10/5/2013
New Strategies for Obesity Management: Risk Stratification & Long-term Weight Control
American Association of Clinical Endocrinologists (AACE), Dearborn, Michigan - 10/5/2013

Press Mentions

Nevro Announces American Association of Clinical Endocrinology Clinical Practice Guideline Has Been Updated to Include High-Frequency 10 kHz Spinal Cord Stimulation to Treat Painful Diabetic NeuropathyOctober 3rd, 2022
Nevro : Revolutionizing the Treatment of Painful Diabetic Neuropathy (PDN) with High Frequency (10 kHz) Spinal Cord StimulationJune 7th, 2022
Panel Provides Update on the Future of Weekly, Oral, and Interchangeable InsulinsJune 6th, 2022
Join now to see all

Grant Support

Natural Insulin Receptor Tyrosine Kinase InhibitorNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994

Committees

member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2029
member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015